Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
29.25    0.00 (0.00%)
Bid:
28.50
Ask:
30.00
Spread: 1.50 (5.263%)
Market Cap: £123.62m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Director Shareholding

23 Jul 2010 07:00

RNS Number : 8013P
Merchant Securities Group PLC
23 July 2010
 



AIM: MERC

 

MERCHANT SECURITIES GROUP PLC

("Merchant Securities" or "the Company")

 

Director Shareholdings

 

Merchant Securities, the financial services group, announces that the Board today approved the grant of options over the Company's ordinary shares, under the terms of the Merchant Securities Group plc Executive option scheme, and that the trustees of the Merchant Employee Benefit Trust ("EBT") have allocated a proportion of the ordinary shares of 1p each in the Company ("Shares") held by the EBT to Directors of the Company.

 

The Board has granted options over 550,000 ordinary shares ("Options") to Patrick Claridge, Chief Executive of the Company. The Options have been granted at 30p per share, representing a premium of 25 per cent. over the closing middle-market price on 22 July 2010. The Options vest as to one third on the first anniversary of the date of grant, one third on the second anniversary of the date of grant and the balance on the third anniversary of the date of grant. Upon vesting, the Options are exercisable until 22 July 2020.

 

Following the grant of these Options, Mr Claridge holds options over the following ordinary shares in the Company:

 

Number of options

Exercise Price

Exercise Period

550,000

30p

From 23 July 2011 until 22 July 2020

562,514

10p

From 9 September 2009 until 8 September 2019

 

In addition, Mr Claridge and Mr Foster-Powell, Chief Financial Officer of the Company, have been allocated 87,500 and 18,750 Shares, respectively, as part of the deferred equity element of an incentive award made by the Remuneration Committee, currently held by the EBT, relating to the financial performance of the Company in the year ended 31 March 2010. These Shares will be held by the Trustees of the EBT as nominee and will transfer on the second anniversary of the date of allocation.

 

Following the allocation by the EBT, Mr Claridge and Mr John Foster-Powell will be beneficially interested in 2,735,528 and 618,750 ordinary shares of 1p each respectively, equivalent to 5.83 per cent. and 1.32 per cent. of the issued share capital of the Company, respectively.

 

 

For further information please contact:

 

   

Merchant Securities Group plc

Patrick Claridge, Chief Executive

 

  T: 020 7628 2200
Arden Partners plc

Richard Day

Matthew Armitt

 

  T: 020 7614 5917
Biddicks

Katie Tzouliadis

Sophie Lane

 

  T: 020 7448 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSRTMRTMBBTBPM
Date   Source Headline
5th Oct 20177:00 amRNSFurther significant fund realisation achieved
3rd Oct 20177:00 amRNSWebsite launch
20th Sep 20177:00 amRNS£3.1million syndicated investment
18th Sep 201711:05 amRNSResult of AGM
18th Sep 20177:00 amRNSAGM statement
21st Aug 20177:00 amRNS£2.0m investment into Oxford Genetics
2nd Aug 20177:00 amRNSBoard Change
25th Jul 20177:00 amRNSGrant Options & PDMR Dealings
21st Jul 20177:00 amRNSPublication of Annual Report
13th Jul 20177:00 amRNSMercia invests additional £2.0million into nDreams
3rd Jul 20177:00 amRNSPreliminary results
21st Jun 20177:00 amRNSInvestment into Impression Tech & Sector Update
6th Jun 20177:00 amRNSFurther investment into Oxford Genetics
3rd May 20177:00 amRNSNotice of Preliminary Results
22nd Feb 20177:00 amRNSTwo major contracts for Northern Powerhouse Funds
17th Feb 201712:00 pmRNSNotification of Major Interest in Shares
16th Feb 201710:43 amRNSResult of General Meeting & Completion of Placing
31st Jan 20172:40 pmRNSPlacing of new Ordinary Shares to raise c.£40.0m
26th Jan 20177:00 amRNSNotice of Mercia Annual Gala Dinner
18th Jan 20177:00 amRNSNew Direct Investment in Faradion Limited
16th Dec 20167:00 amRNSSale of Allinea Software Limited to ARM
16th Nov 20167:00 amRNS£1m invested in nDreams as part of £2m syndication
10th Nov 20167:00 amRNSHalf Year Results
28th Oct 20167:00 amRNSNotice of Results
27th Oct 20167:00 amRNSInvestment in Oxford Genetics Limited
19th Oct 20167:00 amRNSWarwick Audio Technologies strengthens Board
11th Oct 20167:00 amRNSDigital & Digital Entertainment Portfolio Update
5th Oct 20167:00 amRNSCapital Markets Event
27th Sep 20167:00 amRNSInvestment into innovative healthcare - Medherant
19th Sep 201610:36 amRNSResult of AGM
26th Aug 20167:00 amRNSDirector/PDMR Shareholdings
29th Jul 20167:00 amRNSPublication of Annual Report
28th Jul 20167:00 amRNSGrant Options & PDMR Dealings
26th Jul 20168:30 amRNSRe. Admission to AIM of Concepta PLC
21st Jul 20167:00 amRNSnDreams launches The Assembly for Oculus RIFT
7th Jul 20167:00 amRNSAcquisition, Placing & Open Offer, Change of Name
7th Jul 20167:00 amRNSFundraising & AIM Admission of Direct Investment
30th Jun 20167:00 amRNSPreliminary Results
20th Jun 20167:00 amRNSFour New University Partnerships
1st Jun 20167:00 amRNSNotice of Preliminary Results
26th May 20167:00 amRNSBoard Changes
20th May 20167:00 amRNSMercia's nDreams signs Google VR app deal
9th May 20167:00 amRNSFirst Direct Investment via Enterprise Ventures
17th Mar 20163:30 pmRNSNotification of Major Interest in Shares
17th Mar 20167:00 amRNSNew Direct Investment
10th Mar 20167:02 amRNSAcquisition of Enterprise Ventures
21st Jan 20167:00 amRNSNotice of Mercia Fund Management AGM
15th Dec 20157:00 amRNSThree additional university partnerships
3rd Dec 20157:00 amRNSHalf Yearly Report
10th Nov 20157:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.